Sandoz: Upgrading To A Buy On 2028 Expectations #Sandoz #Upgrading #Buy #Expectations
Tag: Sandoz
Sandoz posts steady FY24 results, cautious FY25 outlook, Biosimilars in focus
Sandoz posts steady FY24 results, cautious FY25 outlook, Biosimilars in focus#Sandoz #posts #steady #FY24 #results #cautious…
Sandoz settles US antitrust case for $275m By Investing.com
Sandoz (SIX:), a division of Novartis (SIX:), has reached a $275 million settlement agreement with the…